作者: Nesrine Z Mostafa , Hasan Uludağ , Mathew Varkey , Douglas N Dederich , Michael R Doschak
DOI: 10.2174/1874210601105010139
关键词: Periodontitis 、 Dental alveolus 、 Cancer research 、 Dexamethasone 、 Tooth loss 、 In vitro 、 Tissue engineering 、 Medicine 、 Dentistry 、 Bone regeneration
摘要: Background And Objective: Periodontitis is an inflammatory disease causing bone loss, and a primary cause of tooth loss. Gingival fibroblasts are readily available with minimal donor site morbidity may be ideal for tissue engineering efforts in regenerating lost alveolar bone. Dexamethasone (Dex) commonly employed vitro osteogenic induction variety cells, but its effect on human gingival (HGF) still controversial. Therefore, the aim our study was to investigate differentiation HGF following Dex treatment.